Insiders Trades
Medical Properties Trust Inc Stock: price and insider trades · United States
1 insider bought €8,170 of shares over the last 90 days, the latest filed 20 Aug 2026.
Medical Properties Trust Inc: what insiders have been doing
Medical Properties Trust Inc, classified in the Real Estate sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 18 October 2026, the company's managers filed 39 filings, from 14 insiders.
On the market, 1 insider bought (1 purchase totalling €8,170) while 2 insiders sold (2 sales totalling €264k). Taken together, the sales exceed the purchases by €256k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 finance chief. The largest single trade was a sale of €256k by Stewart Michael G, published on 21 November 2025.
The most recent open-market purchase was published on 20 August 2026, 58 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
With 39 filings in twelve months, the company is more active than the median of 19 filings across the 5,808 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 3 purchases and 12 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 972.0 m USD and net income of -277.0 m USD, with a dividend of 0.33 USD per share.
Other companies in the same sector with recent insider buying flagged by our signals: Agree Realty Corp and Simon Property Group Inc /DE/. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
196
Thresholds
n/a
Buy Volume
€91,997
3 ops. · all time
Sell Volume
€18M
12 ops. · all time
Who traded when
BuySaleJames Kevin Hanna2 buys1 sale
Michael G. Stewart2 sales
Rosa Handley Hooper2 sales
Since the insiders bought
- -25.7%Entry US$4.12 · Close 14 Oct 2026 US$3.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$3.13
Analyst consensus
6 analysts2.88/5
US$4.25Target US$5.13(+64%)US$7.00
Income statement
RevenueUS$972M
Gross profitUS$935.6M96% margin
EBITDAUS$812.6M84% margin
Net income-US$277M-2.7% margin
Valuation
PER (forward)62.6x
P/Book0.4x
Beta1.49
Balance sheet & cash
Market capUS$1.9B
Total debtUS$9.8B
Free Cash FlowUS$230.8M
Debt / Equity216%
Profitability & ownership
ROE-0.6%
ROA2.8%
% insiders8.8%
% institutions63.1%
Last declaration on 7 October 2026
Declarations196 total
109,433 shares@ US$3.510.019% mcap2.0% of flowCommon stock, par value $0.001SEC:0001193125-26-417145:0
48,548 shares@ US$3.510.0086% mcap2.0% of flowCommon stock, par value $0.001SEC:0001193125-26-417144:0
4,048 shares@ US$3.510.0007% mcap4.7% of flowCommon stock, par value $0.001SEC:0001193125-26-417143:0
3,295 shares@ US$3.510.0006% mcap2.9% of flowCommon stock, par value $0.001SEC:0001193125-26-417142:0
1,938 shares@ US$3.510.0003% mcap12.5% of flowCommon stock, par value $0.001SEC:0001193125-26-417141:0
2,347 shares@ US$3.510.0004% mcap11.8% of flowCommon stock, par value $0.001SEC:0001193125-26-417140:0
2,300 shares@ US$4.150.0004% mcap2.4% of flowCommon stock, par value $0.001SEC:0001193125-26-359423:0
Canonical exit: 18 Nov 2026 (T+90)
2,347 shares@ US$4.610.0005% mcap17.3% of flowCommon stock, par value $0.001SEC:0001193125-26-298833:0
109,433 shares@ US$4.610.023% mcap2.6% of flowCommon stock, par value $0.001SEC:0001193125-26-298832:0
48,548 shares@ US$4.610.010% mcap2.6% of flowCommon stock, par value $0.001SEC:0001193125-26-298829:0
3,295 shares@ US$4.610.0007% mcap3.9% of flowCommon stock, par value $0.001SEC:0001193125-26-298831:0
1,938 shares@ US$4.610.0004% mcap18.6% of flowCommon stock, par value $0.001SEC:0001193125-26-298828:0
4,048 shares@ US$4.610.0009% mcap6.4% of flowCommon stock, par value $0.001SEC:0001193125-26-298830:0
109,433 shares@ US$4.672.6% of flowCommon stock, par value $0.001SEC:0001193125-26-148528:0
48,548 shares@ US$4.672.6% of flowCommon stock, par value $0.001SEC:0001193125-26-148527:0
3,295 shares@ US$4.673.9% of flowCommon stock, par value $0.001SEC:0001193125-26-148523:0
1,938 shares@ US$4.6718.4% of flowCommon stock, par value $0.001SEC:0001193125-26-148524:0
4,048 shares@ US$4.676.3% of flowCommon stock, par value $0.001SEC:0001193125-26-148526:0
2,347 shares@ US$4.6717.2% of flowCommon stock, par value $0.001SEC:0001193125-26-148525:0
75,000 shares0Common stock, par value $0.001SEC:0001969950-26-000004:0
42,500 shares0Common stock, par value $0.001SEC:0001969905-26-000004:0
75,000 shares0Common stock, par value $0.001SEC:0001665881-26-000004:0
50,000 shares0Common stock, par value $0.001SEC:0001225492-26-000004:0
30,303 shares0Common stock, par value $0.001SEC:0001193125-26-009188:0
2,836 shares@ US$5.0422.4% of flowCommon stock, par value $0.001SEC:0001193125-26-009144:0
25 of 196 declarations
About Medical Properties Trust Inc
Medical Properties Trust, Inc. (NYSE: MPT) is a United States-listed company on the NYSE, headquartered in Birmingham, Alabama, United States. Founded in 2003, MPT was built around a focused real estate thesis: acquire and develop hospital facilities and lease them to healthcare operators under long-term net lease structures. This makes MPT a specialized healthcare real estate investment trust rather than an operator of medical services. Its earnings model is therefore driven primarily by contractual rental income, asset management, capital allocation, and the credit quality of its tenants.
The company’s core activities center on hospital real estate ownership, sale-leaseback transactions, property acquisitions, financing solutions secured by healthcare assets, and selective portfolio recycling. Over time, MPT has expanded beyond general acute-care hospitals to include behavioral health and post-acute facilities. That broader mix gives the portfolio some operational diversification, though the business remains highly sensitive to tenant performance, reimbursement pressures, and the financial health of hospital operators. In competitive terms, MPT is one of the best-known global hospital landlords, with the scale and specialization to execute large and complex transactions. Its niche expertise is an important advantage, but it also creates a risk profile that is more idiosyncratic than that of a diversified REIT.
Read moreShow less
MPT does not manufacture medical products or provide clinical care. Its “products” are capital and real estate solutions: long-dated leases, structured financing, sale-leasebacks, and hospital-focused property ownership. This specialization is the company’s main differentiator, because financing hospitals requires deep knowledge of healthcare operations, regulatory environments, and capital intensity. Hospitals typically require significant ongoing investment, which supports long-term demand for specialized real estate capital providers like MPT.
Geographically, MPT has historically built a multinational platform, with properties in the United States and several international markets. That footprint offers diversification, but it also introduces cross-border execution, regulatory, and currency considerations. The company’s recent disclosures emphasize continued active portfolio management, debt and liquidity discipline, and capital recycling.
Recent notable developments include the company’s branding refresh and NYSE ticker change from MPW to MPT, effective February 2, 2026, as well as the release of first-quarter 2026 results and the declaration of a quarterly dividend of $0.09 per share. Management commentary has also highlighted ongoing efforts to manage tenant-related risks, monetize selected investments, and strengthen the balance sheet. For international equity investors, MPT remains a highly specialized healthcare REIT with a distinctive risk-return profile: structurally exposed to essential hospital infrastructure, but also to tenant concentration, refinancing conditions, and operator-specific stress.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
